Cencora (BSP:C1CO34) Cyclically Adjusted Revenue per Share: R$3,264.08 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:C1CO34 Cencora Inc BSP:C1CO34
77 GF Score
Price R$707.04
GF Value R$664.91
! 2 Warning Signs
View Full Analysis

What is Cencora Cyclically Adjusted Revenue per Share?

Cencora BSP:C1CO34 77 Cyclically Adjusted Revenue per Share is R$3,264.08 as of Jun. 2026. GuruFocus rates BSP:C1CO34 with a GF Score™ of 77/100 and a GF Value™ of R$664.91. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cencora's adjusted revenue per share for the three months ended in Jun. 2026 was R$1,119.633. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$3,264.08 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Cencora's average Cyclically Adjusted Revenue Growth Rate was 10.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 13.80% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Cencora was 16.90% per year. The lowest was 11.30% per year. And the median was 14.90% per year.

As of today (2026-08-30), Cencora's current stock price is R$707.04. Cencora's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was R$3,264.08. Cencora's Cyclically Adjusted PS Ratio of today is 0.22.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cencora was 0.30. The lowest was 0.14. And the median was 0.19.


Cencora  (BSP:C1CO34) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Cencora's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=707.04/3264.08
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Cencora was 0.30. The lowest was 0.14. And the median was 0.19.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cencora Cyclically Adjusted Revenue per Share Related Terms


Cencora Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Cencora's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora Cyclically Adjusted Revenue per Share Chart

Cencora Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,055.61 2,450.21 2,506.26 3,253.42 3,175.99

Cencora Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,110.85 3,175.99 3,458.28 3,793.79 3,264.08

BSP:C1CO34 vs CAH, MCK, HSIC: Cyclically Adjusted Revenue per Share Comparison

For the Medical Distribution subindustry, Cencora's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cencora Cyclically Adjusted PS Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Cencora's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cencora's Cyclically Adjusted PS Ratio falls into.


BSP:C1CO34
77GF Score
Cencora Inc BSP:C1CO34
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cencora Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cencora's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1119.633/333.9520*333.9520
=1,119.633

Current CPI (Jun. 2026) = 333.9520.

Cencora Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 269.267 241.428 372.460
201612 288.360 241.432 398.863
201703 262.585 243.801 359.682
201706 287.452 244.955 391.889
201709 276.854 246.819 374.590
201712 301.910 246.524 408.980
201803 302.628 249.554 404.975
201806 368.476 251.989 488.328
201809 409.042 252.439 541.122
201812 411.922 251.233 547.548
201903 391.361 254.202 514.141
201906 413.024 256.143 538.489
201909 439.455 256.759 571.574
201912 473.361 256.974 615.159
202003 559.475 258.115 723.855
202006 572.581 257.797 741.725
202009 651.510 260.280 835.919
202012 653.241 260.474 837.516
202103 668.038 264.877 842.250
202106 642.736 271.696 790.012
202109 737.582 274.310 897.951
202112 798.404 278.802 956.337
202203 677.470 287.504 786.919
202206 715.951 296.311 806.900
202209 763.959 296.808 859.565
202212 798.870 296.797 898.878
202303 809.091 301.836 895.180
202306 794.962 305.109 870.112
202309 836.829 307.789 907.962
202312 877.006 306.746 954.790
202403 846.741 312.332 905.353
202406 999.444 314.175 1,062.358
202409 1,105.123 315.301 1,170.494
202412 1,273.522 315.605 1,347.555
202503 1,113.488 319.799 1,162.766
202506 1,145.684 322.561 1,186.143
202509 1,149.371 324.800 1,181.757
202512 1,200.137 324.054 1,236.794
202603 1,048.633 330.213 1,060.507
202606 1,119.633 333.952 1,119.633

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of R$3,264.08 mean?
Cencora (BSP:C1CO34) has a Cyclically Adjusted Revenue per Share of R$3,264.08 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cencora and its competitors.
Is Cencora's Cyclically Adjusted Revenue per Share too high?
Cencora's current Cyclically Adjusted Revenue per Share is R$3,264.08. Overall, Cencora has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Cencora's Cyclically Adjusted Revenue per Share compare to CAH and MCK?
Cencora's Cyclically Adjusted Revenue per Share of R$3,264.08 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Distribution company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Distribution industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Cencora and its competitors. Cencora's current Cyclically Adjusted Revenue per Share is R$3,264.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Cencora (BSP:C1CO34) has a current Cyclically Adjusted Revenue per Share of R$3,264.08. The stock's GF Value™ is R$664.91, compared to a current price of R$707.04 — trading 6.3% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is R$3,264.08. Cencora's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Cencora (BSP:C1CO34), the current Cyclically Adjusted Revenue per Share is R$3,264.08 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cencora (BSP:C1CO34) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be overvalued. The current stock price of R$707.04 is trading 6.3% above its estimated GF Value™ of R$664.91.

Key valuation signals for BSP:C1CO34:

  • Cyclically Adjusted Revenue per Share: R$3,264.08
  • GF Value™: R$664.91 vs. price of R$707.04 (6.3% above fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the BSP:C1CO34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
77GF Score

Get the complete analysis for BSP:C1CO34

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$707.04
Price
R$664.91
GF Value